Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Aegis Logistics Commissions Phase 1 Of Bulk Liquid Terminal At Haldia

Aegis Logistics Ltd. said its Group announced the successful Phase 1 commissioning of the bulk liquid terminal located at Haldia. The new terminal shall store and handle liquid cargo, furnace oil, lube oil, among others.

The capacity expansion at Haldia is a Greenfield Project to set up bulk liquid terminal with 19 tanks totaling to the storage capacity of 60,190 KL. Now with Phase 1 commissioning, 5 tanks will be operational and will have a storage capacity of 15,100 KL. The company is now confident to commission the balance capacity by Q1FY14.

With this new capacity at Haldia, Aegis Group will be handling liquid volumes of over 2.5 million MT and gas volumes of over 750,000 MT.

The company said the expanded facilities at the Eastern Port should enable it to expand its horizons by catering to market of North-East and Eastern States as well as opportunity to handle products for neighboring countries, namely, Bangladesh, Nepal, etc.

Haldia Port is a part of Kolkata Port, the only reverine major port in India situated on the bank of the Hooghly river, 126 miles from the sea. It serves a vast hinterland consisting of almost the entire country's east and north-east, Nepal and Bhutan.

At the BSE, Aegis Logistics shares are currently trading at Rs.128, up 1.19 percent from the previous close.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Here is a list of interesting stocks to watch on December 19. The good news is you can skip this step. There is a next move that can make your life a lot easier. Our research team has already done the groundwork for you. All these stocks listed below and many more have been researched already, and... Shares of OvaScience Inc. (OVAS) have had a strong run in 2014, rising over 370 percent year-to-date. And that's indeed a very impressive return delivered by the fertility treatment company, which suffered a setback last year when it had to suspend a U.S. trial of its flagship fertility treatment due to regulatory concerns raised by the FDA. Nike Inc., the world's largest athletic shoes and apparel maker, said Thursday after the markets closed that its second quarter profit rose 23% from last year, helped by higher revenue and improved gross margin. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.